Status:
UNKNOWN
The Premedication Properties of Oral Melatonin in Pediatrics Undergoing Therapeutic Cardiac Catheterization
Lead Sponsor:
Al-Azhar University
Conditions:
Anesthesia
Eligibility:
All Genders
4-12 years
Phase:
NA
Brief Summary
The evaluation of oral melatonin efficacy as premedicant agent in pediatrics undergoing elective cardiac interventions is the primary outcomes of our trail.
Detailed Description
About 65 % of children whom undergoing surgery and anesthesia are suffering from keen anxiety and stress especially in the preoperative holding area. This situation mostly extends to the parents and t...
Eligibility Criteria
Inclusion
- Age between 4-12 years.
- scheduled for elective therapeutic cardiac catheterization
- ASA I and II
Exclusion
- ASA III or more than.
- Drug allergy.
- Any of contraindication for general anesthesia.
- Mental and neurological diseases.
- disapproval or dissatisfaction
- Liver disease
- Diabetic children
- Thyroid storm
- Sleep disorders
- Intake of antipsychotics.
Key Trial Info
Start Date :
September 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 15 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06031961
Start Date
September 10 2023
End Date
August 15 2024
Last Update
September 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ministry of Health
Baghdad, Thi-Qar, Iraq, 00964